NCT06626490

Brief Summary

The study design is confirmative for non-inferiority of the functional outcome of the implants and is intended to examine the safety and performance of the Prevision hip stem. The study is an observational post-market clinical follow-up study, and the study sites chose the stem variant depending on their own routine and indication.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
95mo left

Started Apr 2026

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Apr 2026Mar 2034

First Submitted

Initial submission to the registry

September 19, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 3, 2024

Completed
1.5 years until next milestone

Study Start

First participant enrolled

April 7, 2026

Completed
6.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2033

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2034

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

6.9 years

First QC Date

September 19, 2024

Last Update Submit

April 30, 2026

Conditions

Keywords

Patient-reported outcomesClinical performance and safetyTotal hip arthroplasty implantation

Outcome Measures

Primary Outcomes (1)

  • Functional outcome of the hip revision surgery

    Oxford Hip Score:The Oxford Hip Score (OHS) is a joint-specific, patient-reported outcome measure designed to assess disability in patients undergoing total hip replacement (THR)

    after two years

Secondary Outcomes (7)

  • Kaplan-Meier survival

    after two years

  • EQ-5D-5L Quality of Life

    visits after 2 and 5 years

  • Complications

    visits after 2 and 5 years

  • Patient satisfaction

    visits after 2 and 5 years

  • Pain (VAS Score)

    visits after 2 and 5 years

  • +2 more secondary outcomes

Interventions

The Prevision hip endoprosthetic stem is a femoral part of a hip joint endoprosthesis. The system provides cementless and cemented variants. Prevision hip stems are modular with a short proximal and longer distal component, or monobloc hip stems. Modular components are coupled via a Prevision specific conical connection with a torque wrench and a tension nut to apply a predefined torsional moment on the connection. The distal component of modular Prevision stems can be combined with locking screws for additional bone fixation. Both types, the monobloc and the modular, provide a 12/14 taper that serves as a connection for metal or ceramic prosthesis heads. Prevision hip stems are combined at the acetabulum with a cementless or cemented acetabular cup.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with indication of a hip revision

You may qualify if:

  • Revision hip arthroplasty patients treated with a Prevision hip stem
  • Written patient informed consent
  • Patients are able to attend at follow-up examinations

You may not qualify if:

  • Patients \< 18 years at surgery
  • Pregnancy at implantation
  • Patients held in a custodial setting
  • Patients in a relationship of dependence on the sponsor, the clinic or the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Orthopädische Kliniken im Annastift, MHH, Anna-von-Borries-Str. 1-7

Hanover, 30625, Germany

RECRUITING

Hinchingbrooke Hospital

Huntingdon, Cambridgeshire, PE29 6NT, United Kingdom

RECRUITING

Study Officials

  • Henning Windhagen, Prof. Dr.

    Orthopädische Kliniken im Annastift, MHH

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kerstin Bergmann

CONTACT

Lutz Dreyer, Dr.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2024

First Posted

October 3, 2024

Study Start

April 7, 2026

Primary Completion (Estimated)

March 1, 2033

Study Completion (Estimated)

March 1, 2034

Last Updated

May 1, 2026

Record last verified: 2026-04

Locations